SCHEMBL5657855

SCHEMBL5657855

CCOc1ccccc1N(CCN1CCN(c2ccccc2F)CC1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 1/20 0.52
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HTR1A P08908 3/20 0.49
ADRA1A P35348 3/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
HTR7 P34969 1/20 0.49
MEN1 O00255 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
DRD2 P14416 2/20 0.48
HTR2A P28223 1/20 0.48
HRH1 P35367 1/20 0.48
PKM P14618 1/20 0.48
OPRM1 P35372 1/20 0.46
OPRL1 P41146 1/20 0.46
DRD4 P21917 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656115 0.94 TP53 (0.51) KMT2ATP53MAPTALDH1A1KDM4E
SCHEMBL5654959 0.90 HTR1A (0.55) KMT2AALDH1A1KDM4EHTR1AADRA1A
SCHEMBL5666364 0.89 HTR1A (0.50) HTR1AADRA1ACYP3A4CYP2D6HTR7
SCHEMBL5656672 0.89 HTR1A (0.57) KMT2AALDH1A1KDM4EHTR1AADRA1A
SCHEMBL5657837 0.86 HTR1A (0.56) MAPTALDH1A1HTR1AADRA1AHTR7
SCHEMBL5657912 0.84 HTR1A (0.50) ALDH1A1KDM4EHTR1ACYP3A4CYP2D6
SCHEMBL5655964 0.84 DRD2 (0.54) KMT2AALDH1A1KDM4EHTR1AADRA1A
SCHEMBL5655903 0.83 DRD2 (0.50) KDM4EHTR1AHTR7DRD2HTR2A
SCHEMBL5654884 0.83 DRD2 (0.61) KMT2AALDH1A1KDM4EHTR1AHTR7
SCHEMBL5655950 0.82 HTR1A (0.50) MAPTHTR1AADRA1AHTR7HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C KMT2A 2124/4885TP53 4247/4885MAPT 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.